ReP USP - Resultado da busca

Artigo de periodico
Impact of continuous Kangaroo mother care initiated immediately after birth (iKMC) on survival of newborns with birth weight between 1.0 to < 1.8 kg: study protocol for a randomized controlled trial (2020)
Castro, Cynthia Pillegi; Adejuyigbe, Ebunoluwa Aderonke; Anand, Pratima; Ansong, Daniel; Anyabolu, Chineme Henry; Arya, Sugandha; Assenga, Evelyne; Awowole, Ibraheem; Bahl, Monika; Bahl, Rajiv
Source: Trials. Unidade: FMRP
Subjects: MÉTODO MÃE CANGURU, RECÉM-NASCIDO DE BAIXO PESO, MORTALIDADE, RELAÇÕES MÃE-CRIANÇA, AMAMENTAÇÃO NATURAL, UNIDADES DE TERAPIA INTENSIVA, NEONATOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, Cynthia Pillegi et al. Impact of continuous Kangaroo mother care initiated immediately after birth (iKMC) on survival of newborns with birth weight between 1.0 to < 1.8 kg: study protocol for a randomized controlled trial. Trials, v. 21, p. 1-13, 2020Tradução . . Disponível em: https://doi.org/10.1186/s13063-020-4101-1. Acesso em: 15 nov. 2024.
APA
Castro, C. P., Adejuyigbe, E. A., Anand, P., Ansong, D., Anyabolu, C. H., Arya, S., et al. (2020). Impact of continuous Kangaroo mother care initiated immediately after birth (iKMC) on survival of newborns with birth weight between 1.0 to < 1.8 kg: study protocol for a randomized controlled trial. Trials, 21, 1-13. doi:10.1186/s13063-020-4101-1
NLM
Castro CP, Adejuyigbe EA, Anand P, Ansong D, Anyabolu CH, Arya S, Assenga E, Awowole I, Bahl M, Bahl R. Impact of continuous Kangaroo mother care initiated immediately after birth (iKMC) on survival of newborns with birth weight between 1.0 to < 1.8 kg: study protocol for a randomized controlled trial [Internet]. Trials. 2020 ; 21 1-13.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1186/s13063-020-4101-1
Vancouver
Castro CP, Adejuyigbe EA, Anand P, Ansong D, Anyabolu CH, Arya S, Assenga E, Awowole I, Bahl M, Bahl R. Impact of continuous Kangaroo mother care initiated immediately after birth (iKMC) on survival of newborns with birth weight between 1.0 to < 1.8 kg: study protocol for a randomized controlled trial [Internet]. Trials. 2020 ; 21 1-13.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1186/s13063-020-4101-1
Artigo de periodico
Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017 (2019)
Goulart, Alessandra Carvalho; Christopher, D J; Doku, D T; Hostiuc, M
Source: Lancet Respiratory Medicine. Unidade: HU
Subjects: MORTALIDADE, MORBIDADE, HOSPITALIZAÇÃO, INFECÇÕES RESPIRATÓRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOULART, Alessandra Carvalho et al. Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017. Lancet Respiratory Medicine, v. 7, n. 1, p. 69-89, 2019Tradução . . Disponível em: https://doi.org/10.1016/S2213-2600(18)30496-X. Acesso em: 15 nov. 2024.
APA
Goulart, A. C., Christopher, D. J., Doku, D. T., & Hostiuc, M. (2019). Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017. Lancet Respiratory Medicine, 7( 1), 69-89. doi:10.1016/S2213-2600(18)30496-X
NLM
Goulart AC, Christopher DJ, Doku DT, Hostiuc M. Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017 [Internet]. Lancet Respiratory Medicine. 2019 ; 7( 1): 69-89.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/S2213-2600(18)30496-X
Vancouver
Goulart AC, Christopher DJ, Doku DT, Hostiuc M. Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017 [Internet]. Lancet Respiratory Medicine. 2019 ; 7( 1): 69-89.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/S2213-2600(18)30496-X
Artigo de periodico
SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension (2017)
Galiè, Nazzareno; Jansa, Pavel; Pulido, Tomás; Channick Richard N.; Delcroix, Marion; Ghofrani, Hossein-Ardeschir; Le Brun, Franck-Olivier; Mehta, Sanjay; Perchenet, Loïc; Rubin Lewis J.; Sastry, B.K.S.; Simonneau, Gérald; Sitbon, Olivier; Souza, Rogério; Torbicki, Adam
Source: European Heart Journal. Unidade: FM
Subjects: MORTALIDADE, CATETERISMO CARDÍACO, ESTUDOS RANDOMIZADOS, HIPERTENSÃO PULMONAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GALIÈ, Nazzareno et al. SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension. European Heart Journal, v. 38, n. 15, p. 1147-1155, 2017Tradução . . Disponível em: https://doi.org/10.1093/eurheartj/ehx025. Acesso em: 15 nov. 2024.
APA
Galiè, N., Jansa, P., Pulido, T., Channick Richard N.,, Delcroix, M., Ghofrani, H. -A., et al. (2017). SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension. European Heart Journal, 38( 15), 1147-1155. doi:10.1093/eurheartj/ehx025
NLM
Galiè N, Jansa P, Pulido T, Channick Richard N., Delcroix M, Ghofrani H-A, Le Brun F-O, Mehta S, Perchenet L, Rubin Lewis J., Sastry BKS, Simonneau G, Sitbon O, Souza R, Torbicki A. SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension [Internet]. European Heart Journal. 2017 ; 38( 15): 1147-1155.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1093/eurheartj/ehx025
Vancouver
Galiè N, Jansa P, Pulido T, Channick Richard N., Delcroix M, Ghofrani H-A, Le Brun F-O, Mehta S, Perchenet L, Rubin Lewis J., Sastry BKS, Simonneau G, Sitbon O, Souza R, Torbicki A. SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension [Internet]. European Heart Journal. 2017 ; 38( 15): 1147-1155.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1093/eurheartj/ehx025

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em

Non normalized affiliation

Countries of institutions of collaboration